Showing results (1-10 of 372) with videos related to

Sort By:
Pageof 38
Oncotargets and Therapy|September 10, 2019
Second-generation EGFR and ErbB tyrosine kinase inhibitors as first-line treatments for non-small cell lung cancerShouzheng Wang, Junling Li
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 21, 2016
[Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer]Shouzheng Wang, Junling Li
Oncotarget|November 12, 2016
Clinical data from the real world: efficacy of Crizotinib in Chinese patients with advanced ALK-rearranged non-small cell lung cancer and brain metastasesPuyuan Xing, Shouzheng Wang, Xuezhi Hao, et al.
Journal of Cancer|October 9, 2020
Nab-paclitaxel in combination with Bevacizumab in patients with non-squamous non-small cell lung cancer after failure of at least one prior systemic regimenXuezhi Hao, Yixiang Zhu, Yuxin Mu, et al.
Thoracic Cancer|May 17, 2019
Efficacy and safety of afatinib in a Chinese population with advanced lung adenocarcinoma with sensitive EGFR mutationsShouzheng Wang, Puyuan Xing, Ke Yang, et al.
Frontiers in Oncology|June 17, 2021
Exploration of the Tumor-Suppressive Immune Microenvironment by Integrated Analysis in EGFR-Mutant Lung AdenocarcinomaTeng Li, Xiaocong Pang, Junyun Wang, et al.
Thoracic Cancer|January 30, 2018
Evaluation of calculating carboplatin dosage in carboplatin-pemetrexed therapy as the first-line therapy for Chinese patients with advanced lung adenocarcinomaYixiang Zhu, Puyuan Xing, Shouzheng Wang, et al.
Targeted Oncology|May 25, 2019
Clinical Modality of Resistance and Subsequent Management of Patients with Advanced Non-small Cell Lung Cancer Failing Treatment with OsimertinibYuxin Mu, Xuezhi Hao, Ke Yang, et al.
Thoracic Cancer|July 2, 2022
Disease monitoring of epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor DNAYan Li, Ziyi Xu, Shouzheng Wang, et al.
Thoracic Cancer|September 7, 2021
Comprehensive analysis of treatment modes and clinical outcomes of small cell lung cancer transformed from epidermal growth factor receptor mutant lung adenocarcinomaShouzheng Wang, Tongji Xie, Xuezhi Hao, et al.
Pageof 38